NSEBSECOMMODITYNASDAQNYSEFOREXINDICESAMEXUSA .

Famous Munafa Ebook, free scanners! Intraday scanner, FNO scanner, High profit BTST stocks!

Editas Medicine (EDIT) Technical (Analysis) Reports Editas Medicine ["Technical Analysis"] Reports -USA Stock Exchange MunafaSutra.com

Complete & easy to understand technical analysis of Editas Medicine (EDIT)

Technical Analysis Report for USA stock EDIT Editas Medicine. Dated: 28 Sep 2026 Updated Daily. Stock trades under Health Care Deals in Biotechnology Biological Products No Diagnostic Substances in USA stock exchange

If you are looking for Tomorrow's Movement Predictions for USA stock EDIT Editas Medicine then click here. or read Experts views on Editas Medicine or Forecast & share price targets of Editas Medicine

Editas Medicine Opened at 2.55 and Closed at: 2.51, which is -3.19% of previous session's close. It moved within a range of 2.42 and 2.55
The session was a Bearish session with an average volume of 2204400, which is -22.03% of previous session's volumes.

• The stock has fallen, and its short term trend is also negative and in a downtrend.

Support for tomorrow is 2.4 and resistance for tomorrow is 2.53
These support and resistance points are valid for the first 5-15 minutes charts

Above are simple pivot point calculations. For a list of much stronger support and resistance levels click here. These are way more stronger support and resistance levels, and mark trend reversals and are Support & Resistance levels recommended by experts.

Support for tomorrow's hourly charts is 2.44, 2.36 resistance for tomorrow's hourly charts is 2.57, 2.62

10 Day SMA for Editas Medicine (EDIT) is 2.71 and stock is trading below these levels. This is not a good sign for its short term trend

20 Day SMA for Editas Medicine (EDIT) is 2.82 and the stock is trading below these levels. This is not a good sign for its mid term trend

50 Day SMA for Editas Medicine (EDIT) is 2.85 and the stock is trading below these levels. This is not a good sign for its mid to long term trend

100 Day SMA is 2.9 and the stock is trading below these levels. This is not a good sign for its long term trend

200 Day SMA Editas Medicine is 2.64 and stock is trading below these levels. This is not a good sign for its long term trend

20 DMA of Editas Medicine is at 2.82 and 200 DMA is at 2.64, while 50 DMA and 100 DMA are at 2.85 and 2.9 respectively

Editas Medicine (EDIT) moving average of 20 SMA is at 2.82 and 20 EMA is at 2.77

Editas Medicine (EDIT) moving average of 50 SMA is at 2.85 and 50 EMA is at 2.85

Editas Medicine (EDIT) moving average of 100 SMA is at 2.9 and 100 EMA is at 2.87

Editas Medicine (EDIT) moving average of 200 SMA is at 2.64 and 200 EMA is at 2.69

Unitedhealth Group has performed better than Editas Medicine in short term. You could have earned much better returns by investing in Unitedhealth Group, about 15% more returns!

Iqvia Holdings has performed better than Editas Medicine in short term. You could have earned much better returns by investing in Iqvia Holdings, about 21.71% more returns!

Herbalife Nutrition has performed better than Editas Medicine in short term. You could have earned much better returns by investing in Herbalife Nutrition, about 32.62% more returns!

Charles River has performed better than Editas Medicine in short term. You could have earned much better returns by investing in Charles River, about 20.17% more returns!

Astrazeneca Plc has performed better than Editas Medicine in short term. You could have earned much better returns by investing in Astrazeneca Plc, about 20.45% more returns!

Abbvie Inc has performed better than Editas Medicine in short term. You could have earned much better returns by investing in Abbvie Inc, about 21.82% more returns!

Editas Medicine has performed better than Xenetic Biosciences in short term. Holding Editas Medicine could be a better choice for now!

Editas Medicine has performed better than Ultragenyx Pharmaceutical in short term. Holding Editas Medicine could be a better choice for now!

Prothena Corporation has performed better than Editas Medicine in short term. You could have earned much better returns by investing in Prothena Corporation, about 11.23% more returns!

Editas Medicine has performed better than Oncolytics Biotech in short term. Holding Editas Medicine could be a better choice for now!

Intellia Therapeutics has performed better than Editas Medicine in short term. You could have earned much better returns by investing in Intellia Therapeutics, about 7.68% more returns!

Nucana Plc has performed better than Editas Medicine in short term. You could have earned much better returns by investing in Nucana Plc, about 5.73% more returns!

Neurocrine Biosciences has performed better than Editas Medicine in short term. You could have earned much better returns by investing in Neurocrine Biosciences, about 9.15% more returns!

Editas Medicine has performed better than Meiragtx Holdings in short term. Holding Editas Medicine could be a better choice for now!

Orthopediatrics Corp has performed better than Editas Medicine in short term. You could have earned much better returns by investing in Orthopediatrics Corp, about 14.84% more returns!

Catalyst Biosciences has performed better than Editas Medicine in short term. You could have earned much better returns by investing in Catalyst Biosciences, about 5.5% more returns!

Biogen Inc has performed better than Editas Medicine in short term. You could have earned much better returns by investing in Biogen Inc, about 23.53% more returns!

Editas Medicine Technical analysis of indicators

Price action analysis of Editas Medicine (EDIT) based on a short term time period is negative, but trend is highly volatile. A longer duration price action analysis might give a better picture of the trend in this stock.

ADX buy sell signal for Editas Medicine stock for short term is SELL. Signal strength is Weak and stock is losing momentum.

MACD generated a SELL signal for Editas Medicine in short term and the sell signal is strong.

Editas Medicine Stock is trading near its recent LOWS in short term which reflects strong selling momentum. Bears are getting stronger in this stock.

Ichimoku cloud is of red color and prices are below the red cloud Prices appear to be coming down

CCI has generated a SELL signal for Editas Medicine in short term and SELL signal is strong!

RSI is generating a SELL signal in short term but selling is losing momentum.

MRSI is in negative zone. This is the SELL zone

Although the stock is in the SELL zone, but selling might be slowing down

Stock of Editas Medicine is picking up selling momentum according to indicator.

Volume based indicators are showing selling momentum.

Volume Weighted Averaged Price (VWAP) for short term is 2.7 and Editas Medicine EDIT stock is trading below this level. This means that stock is falling with high volumes. VWAP is falling down

People seem to be coming out and selling the Editas Medicine EDIT stock. Volume based technical analysis of Editas Medicine EDIT stock is negative.

Editas Medicine Stock has given negative returns over a short term period. Returns for a longer term period have been negative.

Force Index is moving in a negative zone, which indicates selling momentum for short term... Selling momentum is getting weaker.

Tomorrow's Predictions

You should also read Tomorrow's Movement Predictions for USA stock EDIT Editas Medicine These predictions are based on various factors, are easy to understand, and upto 75% accurate!

And EDIT Experts View which covers a lot of information including buying and selling signals

EDIT future forecast & share price targets

You can also take a look at the Charts and indicator analysis here Announcements & NEWS by Editas Medicine or View Candle Stick Charts here

Share on: WhatsApp Facebook Tweet